189 related articles for article (PubMed ID: 10632678)
1. Increased levels of circulating soluble CD14 in Kawasaki disease.
Takeshita S; Nakatani K; Tsujimoto H; Kawamura Y; Kawase H; Sekine I
Clin Exp Immunol; 2000 Feb; 119(2):376-81. PubMed ID: 10632678
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the expression of Fc gamma receptor on circulating neutrophils and monocytes in Kawasaki disease.
Nakatani K; Takeshita S; Tsujimoto H; Kawamura Y; Kawase H; Sekine I
Clin Exp Immunol; 1999 Aug; 117(2):418-22. PubMed ID: 10444279
[TBL] [Abstract][Full Text] [Related]
3. Increased percentages of tumor necrosis factor-alpha+/interferon-gamma+ T [corrected] lymphocytes and calprotectin+/tumor necrosis factor-alpha+ monocytes in patients with acute Kawasaki disease.
Guggino G; Cimaz R; Accomando S; Pagnini I; Simonini G; Di Liberto D; De Martino M; Dieli F; Sireci G
Int J Immunopathol Pharmacol; 2012; 25(1):99-105. PubMed ID: 22507322
[TBL] [Abstract][Full Text] [Related]
4. CD14+CD16+ monocyte subpopulation in Kawasaki disease.
Katayama K; Matsubara T; Fujiwara M; Koga M; Furukawa S
Clin Exp Immunol; 2000 Sep; 121(3):566-70. PubMed ID: 10971526
[TBL] [Abstract][Full Text] [Related]
5. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
Ge X; Li CR; Yang J; Wang GB
Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
[TBL] [Abstract][Full Text] [Related]
6. The role of bacterial lipopolysaccharide-bound neutrophils in the pathogenesis of Kawasaki disease.
Takeshita S; Nakatani K; Kawase H; Seki S; Yamamoto M; Sekine I; Yoshioka S
J Infect Dis; 1999 Feb; 179(2):508-12. PubMed ID: 9878040
[TBL] [Abstract][Full Text] [Related]
7. CD14 is an acute-phase protein.
Bas S; Gauthier BR; Spenato U; Stingelin S; Gabay C
J Immunol; 2004 Apr; 172(7):4470-9. PubMed ID: 15034063
[TBL] [Abstract][Full Text] [Related]
8. [Changes and significance for regulatory factors for signal pathways of Toll-like receptors in immunological pathogenesis of Kawasaki disease].
Wang GB; Li CR; Zu Y; Yang WG
Zhonghua Er Ke Za Zhi; 2008 Jan; 46(1):49-54. PubMed ID: 18353240
[TBL] [Abstract][Full Text] [Related]
9. Increased Interleukin-35 suppresses peripheral CD14
Xing H; Tian G
BMC Immunol; 2020 Apr; 21(1):17. PubMed ID: 32276581
[TBL] [Abstract][Full Text] [Related]
10. Childhood nephrotic syndrome in relapse is associated with down-regulation of monocyte CD14 expression and lipopolysaccharide-induced tumour necrosis factor-alpha production.
Chen SP; Cheung W; Heng CK; Jordan SC; Yap HK
Clin Exp Immunol; 2003 Oct; 134(1):111-9. PubMed ID: 12974763
[TBL] [Abstract][Full Text] [Related]
11. Monocyte cell-surface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS.
Nockher WA; Scherberich JE
Kidney Int; 1995 Nov; 48(5):1469-76. PubMed ID: 8544403
[TBL] [Abstract][Full Text] [Related]
12. Activation of peripheral blood monocytes and macrophages in Kawasaki disease: ultrastructural and immunocytochemical investigation.
Koga M; Ishihara T; Takahashi M; Umezawa Y; Furukawa S
Pathol Int; 1998 Jul; 48(7):512-7. PubMed ID: 9701013
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease.
Takeshita S; Tokutomi T; Kawase H; Nakatani K; Tsujimoto H; Kawamura Y; Sekine I
Clin Exp Immunol; 2001 Aug; 125(2):340-4. PubMed ID: 11529928
[TBL] [Abstract][Full Text] [Related]
14. Changes in endotoxin-binding proteins during major elective surgery: important role for soluble CD14 in regulation of biological activity of systemic endotoxin.
Hiki N; Berger D; Dentener MA; Mimura Y; Buurman WA; Prigl C; Seidelmann M; Tsuji E; Kaminishi M; Beger HG
Clin Diagn Lab Immunol; 1999 Nov; 6(6):844-50. PubMed ID: 10548574
[TBL] [Abstract][Full Text] [Related]
15. Increased in vitro production and serum levels of the soluble lipopolysaccharide receptor sCD14 in liver disease.
Oesterreicher C; Pfeffel F; Petermann D; Müller C
J Hepatol; 1995 Oct; 23(4):396-402. PubMed ID: 8655956
[TBL] [Abstract][Full Text] [Related]
16. Endotoxin binding and elimination by monocytes: secretion of soluble CD14 represents an inducible mechanism counteracting reduced expression of membrane CD14 in patients with sepsis and in a patient with paroxysmal nocturnal hemoglobinuria.
Hiki N; Berger D; Prigl C; Boelke E; Wiedeck H; Seidelmann M; Staib L; Kaminishi M; Oohara T; Beger HG
Infect Immun; 1998 Mar; 66(3):1135-41. PubMed ID: 9488406
[TBL] [Abstract][Full Text] [Related]
17. Augmented TLR2 expression on monocytes in both human Kawasaki disease and a mouse model of coronary arteritis.
Lin IC; Kuo HC; Lin YJ; Wang FS; Wang L; Huang SC; Chien SJ; Huang CF; Wang CL; Yu HR; Chen RF; Yang KD
PLoS One; 2012; 7(6):e38635. PubMed ID: 22737215
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of CD14 shedding from human monocytes. Evidence for the competition of soluble CD14 (sCD14) with CD14 receptors for lipopolysaccharide (LPS) binding.
Rokita E; Menzel EJ
APMIS; 1997 Jul; 105(7):510-8. PubMed ID: 9269297
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin does not increase FcgammaRIIB expression on monocytes/macrophages during acute Kawasaki disease.
Ichiyama T; Ueno Y; Hasegawa M; Ishikawa Y; Matsubara T; Furukawa S
Rheumatology (Oxford); 2005 Mar; 44(3):314-7. PubMed ID: 15572393
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of CD23 on peripheral blood macrophages/monocytes during acute Kawasaki disease with coronary artery lesions.
Furukawa S; Matsubara T; Okumura K; Yabuta K
Int Arch Allergy Immunol; 1993; 102(4):335-9. PubMed ID: 7694701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
